Left Main Coronary Artery Disease and Outcomes after Percutaneous Coronary Intervention for Chronic Total Occlusions.

CTO PCI chronic total occlusion coronary artery disease

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
30 Mar 2020
Historique:
received: 20 02 2020
revised: 13 03 2020
accepted: 21 03 2020
entrez: 3 4 2020
pubmed: 3 4 2020
medline: 3 4 2020
Statut: epublish

Résumé

Concomitant left main coronary artery (LMCA) disease in patients with chronic total occlusions (CTO) commonly results in referral for coronary artery bypass grafting, although the impact of LMCA in CTO patients remains largely unknown. Nevertheless, patient selection for percutaneous coronary intervention of CTOs (CTO-PCI) or alternative revascularization strategies should be based on precise evaluation of the coronary anatomy to anticipate those patients that most likely benefit from a procedure and not on strict adherence to perpetual clinical practice. Therefore, the aim of this study was to assess the impact of LMCA disease on long-term outcomes in patients undergoing percutaneous coronary intervention for CTO. We enrolled 3860 consecutive patients undergoing PCI for at least one CTO lesion and investigated the predictive value of concomitant LMCA disease. All-cause mortality was defined as the primary study endpoint. We observed that LMCA disease is significantly associated with mortality. In the Cox regression analysis, we observed a crude hazard ratio (HR) 1.59 (95% confidence interval (CI) 1.23-2.04, LMCA disease is associated with excess mortality in CTO patients. Specifically, anatomical features such as CTO of the circumflex artery represent a high risk patient population.

Sections du résumé

BACKGROUND BACKGROUND
Concomitant left main coronary artery (LMCA) disease in patients with chronic total occlusions (CTO) commonly results in referral for coronary artery bypass grafting, although the impact of LMCA in CTO patients remains largely unknown. Nevertheless, patient selection for percutaneous coronary intervention of CTOs (CTO-PCI) or alternative revascularization strategies should be based on precise evaluation of the coronary anatomy to anticipate those patients that most likely benefit from a procedure and not on strict adherence to perpetual clinical practice. Therefore, the aim of this study was to assess the impact of LMCA disease on long-term outcomes in patients undergoing percutaneous coronary intervention for CTO.
METHODS METHODS
We enrolled 3860 consecutive patients undergoing PCI for at least one CTO lesion and investigated the predictive value of concomitant LMCA disease. All-cause mortality was defined as the primary study endpoint.
RESULTS RESULTS
We observed that LMCA disease is significantly associated with mortality. In the Cox regression analysis, we observed a crude hazard ratio (HR) 1.59 (95% confidence interval (CI) 1.23-2.04,
CONCLUSION CONCLUSIONS
LMCA disease is associated with excess mortality in CTO patients. Specifically, anatomical features such as CTO of the circumflex artery represent a high risk patient population.

Identifiants

pubmed: 32235416
pii: jcm9040938
doi: 10.3390/jcm9040938
pmc: PMC7231249
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Clin Res Cardiol. 2018 Mar;107(3):259-267
pubmed: 29134346
JACC Cardiovasc Interv. 2008 Jun;1(3):295-302
pubmed: 19463316
Rev Esp Cardiol. 2009 Jul;62(7):719-25
pubmed: 19709505
Can J Cardiol. 2014 Dec;30(12):1588-94
pubmed: 25442459
Circulation. 1989 Jun;79(6):1171-9
pubmed: 2785870
J Am Heart Assoc. 2018 Mar 31;7(7):
pubmed: 29605817
EuroIntervention. 2012 May 15;8(1):139-45
pubmed: 22580257
Clin Res Cardiol. 2018 Jun;107(6):449-459
pubmed: 29356881
Indian Heart J. 2018 Sep - Oct;70(5):745-749
pubmed: 30392516
Clin Res Cardiol. 2011 May;100(5):457-67
pubmed: 21165625
Circulation. 1982 Jul;66(1):14-22
pubmed: 6979435
Int J Angiol. 2011 Mar;20(1):33-8
pubmed: 22532768
Catheter Cardiovasc Interv. 2013 Jul 1;82(1):76-82
pubmed: 22888007
Am J Cardiol. 2017 Nov 15;120(10):1780-1786
pubmed: 28867125
JACC Cardiovasc Interv. 2015 Feb;8(2):245-253
pubmed: 25700746
J Card Surg. 2012 Mar;27(2):152-7
pubmed: 22364383
Circulation. 2016 May 3;133(18):1807-16
pubmed: 27143547
Clin Res Cardiol. 2016 Nov;105(11):921-929
pubmed: 27250096

Auteurs

Max-Paul Winter (MP)

Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.

Georg Goliasch (G)

Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.

Philipp Bartko (P)

Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.

Jolanta Siller-Matula (J)

Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.

Mohamed Ayoub (M)

Division of Cardiology and Angiology II, University Heart Center Freiburg-Bad Krozingen, 79189 Bad Krozingen, Germany.

Stefan Aschauer (S)

Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.

Klaus Distelmaier (K)

Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.

Catherine Gebhard (C)

Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.

Kambis Mashayekhi (K)

Division of Cardiology and Angiology II, University Heart Center Freiburg-Bad Krozingen, 79189 Bad Krozingen, Germany.

Miroslaw Ferenc (M)

Division of Cardiology and Angiology II, University Heart Center Freiburg-Bad Krozingen, 79189 Bad Krozingen, Germany.

Christian Hengstenberg (C)

Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.

Aurel Toma (A)

Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.

Classifications MeSH